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Pheromones are chemicals released from the external surfaces of the body, from where 
they diffuse into the surrounding environment and affect the behaviour of other 
individuals (normally of the same species). In mammals they are normally detected in a 
specialised structure called the vomero-nasal organ in the rostral end of the hard palate 
within the nasal cavity. Connection with the oral cavity varies between species. The 
receptors in this organ are neurologically linked to the limbic system of the brain so the 
pheromone molecules can rapidly moderate emotional behaviour without necessarily 
invoking any conscious awareness of this. The term “Pheromone” is derived from the two 
Greek words “pherein” meaning  “to carry” and “horman”  meaning “to stimulate” and 
was first coined by Karlson and Luscher1 to describe these important chemicals. They 
may are also be referred to as ectohormones or social odours, in some situations, but 
regardless of this the term pheromonatherapy is now widely accepted for the use of these 
chemicals in a clinical context to manage the behaviour of mammals. A mixture of 
relatively simple chemicals in a particular combination often forms the specific message, 
but in some situations a single chemical may be sufficient in triggering a response. 
Patrick Pageat, a French veterinary surgeon and behaviour specialist, has been at the 
forefront of the initial isolation of these products in cats and other species, but many other 
scientist have examined their application. In the cat 5 functional fractions (F1-F5) have 
been isolated from the facial secretions, each with a distinct role. Two of these can now 
be synthesised artificially and used to help manage a variety of stressful situations in the 
cat.  More recently, one pheromone has been identified from the inter-mammary sulcus 
of the lactating bitch (Dog Appeasing Pheromone) which appears to have a calming 
affect on this species.  
Initial work focussed on the use of the F3 fraction in the cat2 and showed that both sexual 
urine spraying and reactive (non-sexual) urine spraying could be reduced when it was 
applied to the surrounding environment. Since then several papers have examined the 
effects of F3 and its commercial formulation “Feliway” (Ceva Animal Health) further 
and looked at other applications of the substance. It has been found consistently that urine 
spraying, regardless of cause, reduces in over 70% of cases and in some instances as 
many as 97% of cases following treatment with F3. This compares very favourably with 
psychopharmacological interventions which also carry associated risks not present with 
F3. The long-term findings are also encouraging, with a reported 77% of cases still under 
adequate control 10 months after treatment3 . Careful investigation of those cases which 
respond and those which do not, has helped us to understand the probable mechanism of 
action of these chemicals. The efficacy of  F3 for the control of urine marking has been 
found to be lower in cases where there is also intercat aggression within the household4. 
This is consistent with the idea that urine spraying may be a form of passive aggression 
and that F3 may function in the natural setting to control low level threat situations and 
thereby prevent overt aggression in a social context. It then follows, that once the 
problem has escalated to include overt aggression, additional methods may be required to 
help resolve the conflict. In a domestic setting, this might include behaviour therapy to 
address the relationship between the cats involved and possibly the use of psychoactive 
drugs (especially clomipramine, Clomicalm, Novartis Animal Health) to control the 
situation. Other scientifically demonstrated  effects of F3 include a reduction in transport 
stress and a reduction in overnight roaming from new accommodation. It has also been 
found in numerous case reports that cats tend to avoid scratching where F3 is applied and 
so it ca be used to help redirect problem scratching away from furniture and train them to 
use more acceptable areas like scratching posts.   F3 also has an important role in the 
veterinary surgery. Treatment of cages has been shown to bring a number of significant 
benefits including easier preoperative intravenous catherisation and an improvement in 
the appetite and general demeanour of hospitalised cats. These animals also appear to be 
better able to cope with mild stress5. These effects may not only help speed 
convalescence but have the potential to make the difference between life and death in 
critical cases. A further recent innovation will make treatment even easier, since it has 
now been found that this pheromone can be delivered effectively via a plug-in diffuser, 
similar to that used as a room freshener. A recent study6 has found this method of 
delivery, which requires a single device which lasts 4 weeks for a whole building ,to be 
comparable to the spray in its efficacy with 90% of spraying cats improving following 
treatment and a reduction of 49% within 4 weeks. No behaviour therapy was required to 
achieve this effect and animals with crystalluria or haematuria in the absence of any other 
clinical signs all responded.  
The other feline facial fraction which has been used in a clinical context is F4 (Felifriend, 
Ceva Animal Health). This is only available as a spray and is similarly applied to the 
environment or the potential handler. It has been found that treatment encourages animals 
to approach unfamiliar people and reduces the risk of aggression due to handling in the 
veterinary clinic7. One other study has also found that this chemical helps cats adapt more 
readily to being moved to a shelter environment8 and so it may have an important role to 
play in the rescue sector. Whilst in the vast majority of cases, F4 dramatically reduces the 
risk of aggression whilst being handled, we have reports of a few cases of increased 
aggression. In the small number of cases that we have seen with this reaction, the 
aggression was directed towards someone that the cat already tended to avoid and had 
shown aggression to in the past. We hypothesise that in these cases the cat was receiving 
conflicting signals (chemical signal encouraging it to approach and visual one to run 
away). It then froze and panicked when touched as a result. Thus F4, like F3, may be 
most effective in mild threat situations or those involving uncertainty rather than strong 
aversion. 
The discovery of a dog pheromone with a calming affect presents a further exciting 
opportunity, although data on its efficacy are limited. The product is already produced in 
France for the treatment of the signs of separation anxiety and preliminary studies in this 
country have also been very encouraging. It is likely that it too will help animals adjust to 
situations involving novelty or uncertainty and so its final range of applications may be 
much greater. 
Pheromonatherapy already offers a safe, scientific and effective first line of treatment for 
a range of behaviour problems, and it is likely that the indications will expand in the next 
few years. It is therefore important that veterinary surgeons having at least a working 
knowledge of the subject, so they can not only optimise the welfare of their patients, but 
also potentially reduce the risk of injury to themselves and their colleagues from anxious 
or stressed patients.  
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